BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10549678)

  • 1. Limitations in the study of immune privilege in the subretinal space of the rodent.
    Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3069. PubMed ID: 10549678
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations in the study of immune privilege in the subretinal space of the rodent.
    Al-Amro S; Tang L; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3067-9. PubMed ID: 10549677
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology and privilege of neuronal retina and pigment epithelium transplants.
    Streilein JW; Ma N; Wenkel H; Ng TF; Zamiri P
    Vision Res; 2002 Feb; 42(4):487-95. PubMed ID: 11853765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of superparamagnetic microbeads in tracking subretinal injections.
    Wen J; McKenna KC; Barron BC; Langston HP; Kapp JA
    Mol Vis; 2005 Apr; 11():256-62. PubMed ID: 15851980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoreceptor protection by iris pigment epithelial transplantation transduced with AAV-mediated brain-derived neurotrophic factor gene.
    Hojo M; Abe T; Sugano E; Yoshioka Y; Saigo Y; Tomita H; Wakusawa R; Tamai M
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3721-6. PubMed ID: 15452082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafting of ARPE-19 and Schwann cells to the subretinal space in RCS rats.
    Wang S; Lu B; Wood P; Lund RD
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2552-60. PubMed ID: 15980247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumentation and technique for delivery of tissue explants to the subretinal space.
    Thumann G; Aisenbrey S; Schaefer F; Bartz-Schmidt KU
    Ophthalmologica; 2006; 220(3):170-3. PubMed ID: 16679791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subretinal transplantation of genetically modified human retinal pigment epithelium cells delay photoreceptor degeneration and functional deterioration in rats].
    Huang Q; Wu JH; Wang F; Xu P; Xia X; Yi J; Zhao XF
    Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):552-6. PubMed ID: 15454045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical doxycycline can induce expression of BDNF in transduced retinal pigment epithelial cells transplanted into the subretinal space.
    Abe T; Wakusawa R; Seto H; Asai N; Saito T; Nishida K
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3631-9. PubMed ID: 18660427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of microinjection methods for subretinal RPE transplantation in the rat].
    Zhou ZH; Kaplan HJ
    Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):549-51. PubMed ID: 15454044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin plays a vital role in the immune privilege of the eye.
    Zamiri P; Masli S; Kitaichi N; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):908-19. PubMed ID: 15728547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior segment approach for subretinal transplantation or injection in the canine model.
    Verdugo ME; Ailing J; Lazar ES; del Cerro M; Ray J; Aguirre G
    Cell Transplant; 2001; 10(3):317-27. PubMed ID: 11437077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
    Chen PW; Uno T; Ksander BR
    Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on immune privilege in subretinal space].
    Gao L; Jiang D
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):339-42. PubMed ID: 11189387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological problems of transplantation into the subretinal space.
    Enzmann V; Faude F; Wiedemann P; Kohen L
    Acta Anat (Basel); 1998; 162(2-3):178-83. PubMed ID: 9831766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
    Dace DS; Chen PW; Alizadeh H; Niederkorn JY
    J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.